70202-00-5 Usage
Uses
Used in Pharmaceutical Industry:
6-Benzothiazolamine,7-chloro-(9CI) is used as an intermediate in the synthesis of pharmaceuticals for its reactivity and properties that contribute to the development of new drugs and medicinal compounds.
Used in Dye Industry:
6-Benzothiazolamine,7-chloro-(9CI) serves as an intermediate in the production of dyes, where its chemical structure and reactivity play a crucial role in creating a wide range of colorants for various applications.
Used in Agricultural Chemicals:
6-Benzothiazolamine,7-chloro-(9CI) is utilized as a building block in the synthesis of agricultural chemicals, such as pesticides and herbicides, due to its potential to enhance the effectiveness and properties of these products.
Used in Material Science:
6-Benzothiazolamine,7-chloro-(9CI) finds application in material science, where its unique structure and reactivity contribute to the development of new materials with specific properties for various industrial uses.
Used in Organic Synthesis:
6-Benzothiazolamine,7-chloro-(9CI) is employed as a versatile intermediate in organic synthesis, enabling the creation of a variety of organic compounds for research and commercial purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 70202-00-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,2,0 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 70202-00:
(7*7)+(6*0)+(5*2)+(4*0)+(3*2)+(2*0)+(1*0)=65
65 % 10 = 5
So 70202-00-5 is a valid CAS Registry Number.
70202-00-5Relevant academic research and scientific papers
5- AND 6-(2-IMIDAZOLIN-2-YLAMINO) AND -(2-THIAZOLIN-2-YLAMINO)-BENZOTHIAZOLES AS ALPHA-2 ADRENERGIC LIGANDS
-
, (2008/06/13)
This invention is directed to indole and benzothiazole compounds which are selective for cloned human alpha 2 receptors. This invention is also related to uses of these compounds for any indication where use of an alpha 2 agonist may be appropriate. Specifically, this includes use as analgesic, sedative and anaesthetic agents. In addition, this invention includes using such compounds for lowering intraocular pressure, presbyopia, treating migraine, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, ischemic pain, spasticity, diarrhea, nasal decongestion, urinary incontinence as well as for use as cognition enhancers and ocular vasoconstriction agents. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
